According to Inhibrx's latest financial reports the company's current revenue (TTM) is $1.8 M. In 2022 the company made a revenue of $2.17 M a decrease over the years 2021 revenue that were of $7.12 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $1.8 M | -17.36% |
2022 | $2.17 M | -69.43% |
2021 | $7.12 M | -44.37% |
2020 | $12.8 M | 40.86% |
2019 | $9.09 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | N/A | N/A | ๐บ๐ธ USA |